The neuroprotective effect of olanzapine

dc.contributor.authorOzan, Erol
dc.contributor.buuauthorYuluğ, Burak
dc.contributor.buuauthorBakar, Mustafa
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-9704-6173tr_TR
dc.contributor.researcheridO-8322-2016tr_TR
dc.contributor.researcheridAAD-3930-2022tr_TR
dc.contributor.scopusid6507583384tr_TR
dc.contributor.scopusid26643051200tr_TR
dc.date.accessioned2024-03-28T12:55:52Z
dc.date.available2024-03-28T12:55:52Z
dc.date.issued2008
dc.identifier.citationYuluğ, B. vd. (2008). "The neuroprotective effect of olanzapine". Journal of Neuropsychiatry and Clinical Neurosciences, 20(1), 107-108. en_US
dc.identifier.endpage108tr_TR
dc.identifier.issn0895-0172
dc.identifier.issue1tr_TR
dc.identifier.pubmed18305294tr_TR
dc.identifier.scopus2-s2.0-39749139311tr_TR
dc.identifier.startpage107tr_TR
dc.identifier.urihttps://doi.org/10.1176/appi.neuropsych.20.1.107-a en_US
dc.identifier.urihttps://neuro.psychiatryonline.org/doi/full/10.1176/jnp.2008.20.1.107a en_US
dc.identifier.urihttps://hdl.handle.net/11452/40659 en_US
dc.identifier.volume20tr_TR
dc.identifier.wos000253311000016
dc.indexed.pubmedPubmed en_US
dc.indexed.wosSCIE en_US
dc.language.isoen en_US
dc.publisherAmer Psychiatric Publishing en_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalJournal of Neuropsychiatry and Clinical Neurosciences en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccess en_US
dc.subjectSchizophrenia en_US
dc.subjectNeuroleptics en_US
dc.subjectBrain en_US
dc.subjectNeurosciences & NeurologyPsychiatry Web of Science CategoriesClinical Neurolo en_US
dc.subjectPsychiatry en_US
dc.subject.emtreeDrug vehicle en_US
dc.subject.emtreeNeuroleptic agent en_US
dc.subject.emtreeOlanzapine en_US
dc.subject.emtreeAnimal cell en_US
dc.subject.emtreeAnimal experiment en_US
dc.subject.emtreeAnimal model en_US
dc.subject.emtreeAnimal tissue en_US
dc.subject.emtreeBrain infarction en_US
dc.subject.emtreeControlled study en_US
dc.subject.emtreeDisease course en_US
dc.subject.emtreeDose response en_US
dc.subject.emtreeDrug efficacy en_US
dc.subject.emtreeLetter en_US
dc.subject.emtreeLong term care en_US
dc.subject.emtreeMale en_US
dc.subject.emtreeMiddle cerebral artery occlusion en_US
dc.subject.emtreeMouse en_US
dc.subject.emtreeNeuroimaging en_US
dc.subject.emtreeNeuroprotection en_US
dc.subject.emtreeNeurotoxicity en_US
dc.subject.emtreeNonhuman en_US
dc.subject.emtreeNuclear magnetic resonance imaging en_US
dc.subject.emtreePriority journal en_US
dc.subject.emtreeSchizophrenia en_US
dc.subject.scopusCommon Carotid Artery; Fluoro Jade; Gerbillinae en_US
dc.subject.wosClinical neurology en_US
dc.subject.wosNeurosciences en_US
dc.subject.wosPsychiatry en_US
dc.titleThe neuroprotective effect of olanzapine en_US
dc.typeArticle en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections